Occudo Quantitative Strategies’s Idexx Laboratories IDXX Stock Holding History

Occudo Quantitative Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-341	Closed	-$231K	–	835
2025 Q4	$231K	Sell	341 -8,189	-96%	-$5.58M	0.02%	561
2025 Q3	$5.45M	Buy	8,530 +5,807	+213%	+$3.52M	0.66%	26
2025 Q2	$1.46M	Buy	+2,723	New	+$1.3M	0.16%	166
2025 Q1	–	Sell	-767	Closed	-$317K	–	768
2024 Q4	$317K	Buy	+767	New	+$336K	0.06%	435
2023 Q4	–	Sell	-6,164	Closed	-$2.7M	–	966
2023 Q3	$2.7M	Buy	+6,164	New	+$3.07M	0.35%	51
2022 Q4	–	Sell	-9,365	Closed	-$3.05M	–	1157
2022 Q3	$3.05M	Buy	9,365 +5,829	+165%	+$2.14M	0.24%	103
2022 Q2	$1.24M	Buy	+3,536	New	+$1.44M	0.1%	308
2021 Q2	–	Sell	-693	Closed	-$339K	–	960
2021 Q1	$339K	Buy	+693	New	+$347K	0.07%	452

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Occudo Quantitative Strategies's IDXX Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 341 shares — an estimated $231K sold.

Occudo Quantitative Strategies first reported a position in IDXX in Q1 2021 and held it in 8 quarters. The position peaked at $5.45M in Q3 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Occudo Quantitative Strategies reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Occudo Quantitative Strategies sold 341 Idexx Laboratories shares in Q1 2026, an estimated $231K.
Occudo Quantitative Strategies first reported a position in Idexx Laboratories in Q1 2021 and held it in 8 quarters.
Occudo Quantitative Strategies's Idexx Laboratories position peaked at $5.45M in Q3 2025.
1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.